Novo Nordisk A/S
Pharmaceuticals
Company Summary
Novo Nordisk A/S is a healthcare firm that specialises in pharmaceutical research, development, manufacturing, and marketing. Diabetes and Obesity Care and Biopharm are the two segments in which it operates. Bagsvaerd, Denmark, is the company's headquarters, which was formed in 1923.
Website : https://www.novonordisk.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
24
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
85
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
AAA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Novo Nordisk is a leader among 79 companies in the pharmaceuticals industry.
Temperature Rise :
1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
